Global Sepsis Diagnostics Market 2021-2028

According to this report, the global sepsis diagnostics market is envisioned to surge at a CAGR of 8.18% through the projected period 2021-2028.

The rise in hospital-acquired infections among patients, paired with the increase in the prevalence of sepsis, are key factors supplementing the growth of the sepsis diagnostics market over the forecast period.

Additionally, the growing government initiatives for research activities related to sepsis are generating new opportunities for the studied market. However, the high cost of the instrument and reimbursement issues are likely to limit the global market’s growth.

REGIONAL OUTLOOK

The global sepsis diagnostics market comprises the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.
The Asia-Pacific is anticipated to observe the fastest growth rate in the sepsis diagnostics market over the considered period. The region’s lucrative growth can be attributed to the rapid economic development and advancement in the medical system in emerging economies like China and India. Further, the demand for sepsis diagnostics is expected to surge due to the high mortality rate associated with sepsis disease. Along with this, the rising awareness about sepsis diagnosis and treatment in the region’s nations is expected to counter the adverse effects of the disease. Hence, such factors are driving the growth of the sepsis diagnostics market across the APAC region.

COMPETITIVE OUTLOOK

The enterprises that have established operation in the sepsis diagnostics market are Thermo Fisher Scientific Inc, Bruker Corporation, F Hoffmann-La Roche, Danaher Corporation, Becton Dickinson and Company (CR Bard), Biomerieux SA, EKF Diagnostics, Immunexpress Inc, Response Biomedical Corporation, T2 Biosystems Inc, Luminex Corporation, Abbott Laboratories, and Cytosorbents.
Abbott Laboratories is a global pharmaceutical company engaged in developing, manufacturing, and marketing a wide range of healthcare products. Its product portfolio includes diagnostic systems, neuromodulation devices, medical devices, adult nutritional products, and generic pharmaceuticals. Moreover, the company markets its products under several brand names, such as Oxepa, Alinity, HeartMate, and FreeStyle, among others. Founded in 1944, it has operations across 150 countries, with headquarters located in the United States.

Frequently Asked Questions about the Global Sepsis Diagnostics Market

What is the estimated value of the Global Sepsis Diagnostics Market?

The Global Sepsis Diagnostics Market was estimated to be valued at $519.4 million in 2021.

What is the growth rate of the Global Sepsis Diagnostics Market?

The growth rate of the Global Sepsis Diagnostics Market is 8.1%, with an estimated value of $900.7 million by 2028.

What is the forecasted size of the Global Sepsis Diagnostics Market?

The Global Sepsis Diagnostics Market is estimated to be worth $900.7 million by 2028.

Who are the key companies in the Global Sepsis Diagnostics Market?

Key companies in the Global Sepsis Diagnostics Market include Abbott Laboratories, Becton Dickinson and Company (Cr Bard), Biomerieux Sa, Bruker Corporation, Cytosorbents, Danaher Corporation, EKF Diagnostics, F Hoffmann and Immunexpress Inc.

Report Attribute	Details
No. of Pages	240
Published	April 2021
Forecast Period	2021 - 2028
Estimated Market Value ( USD ) in 2021	$ 519.4 million
Forecasted Market Value ( USD ) by 2028	$ 900.7 million
Compound Annual Growth Rate	8.1%
Regions Covered	Global

1. Global Sepsis Diagnostics Market - Summary

2. Industry Outlook

2.1. Impact of COVID-19 on Sepsis Diagnostics Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Contracts and Partnership
2.6.2. Business Expansion and Divestitures
2.6.3. Acquisitions & Mergers
2.6.4. New Product Launches
2.7. Market Drivers
2.7.1. Rise in Hospital-Acquired Infections Among Patients
2.7.2. Increased Prevalence of Sepsis
2.8. Market Restraints
2.8.1. High Cost Associated With the Instrument
2.8.2. Reimbursement Issues
2.9. Market Opportunities
2.9.1. Growth Opportunities in the Emerging Economies
2.9.2. Rising Government Initiatives for Research Activities Related to Sepsis

3. Global Sepsis Diagnostics Market - by Technology

3.1. Microbiology
3.2. Immunoassay
3.3. Molecular Diagnostics
3.4. Other Technologies

4. Global Sepsis Diagnostics Market - by Diagnostic Method

4.1. Conventional Diagnostics
4.2. Automated Diagnostics

5. Global Sepsis Diagnostics Market - by Product

5.1. Blood Culture Media
5.2. Assay Kits & Reagents
5.3. Instruments

6. Global Sepsis Diagnostics Market - by Pathogen

6.1. Gram - Positive and Gram - Negative Bacterial Sepsis
6.2. Fungal Sepsis
6.3. Other Pathogens

7. Global Sepsis Diagnostics Market - by Testing Type

7.1. Laboratory Testing
7.2. Point-Of-Care Testing

8. Global Sepsis Diagnostics Market - Regional Outlook

8.1. North America
8.1.1. Market by Technology
8.1.2. Market by Diagnostic Method
8.1.3. Market by Product
8.1.4. Market by Pathogen
8.1.5. Market by Testing Type
8.1.6. Country Analysis
8.1.6.1. United States
8.1.6.2. Canada
8.2. Europe
8.2.1. Market by Technology
8.2.2. Market by Diagnostic Method
8.2.3. Market by Product
8.2.4. Market by Pathogen
8.2.5. Market by Testing Type
8.2.6. Country Analysis
8.2.6.1. Germany
8.2.6.2. France
8.2.6.3. United Kingdom
8.2.6.4. Italy
8.2.6.5. Russia
8.2.6.6. Spain
8.2.6.7. Rest of Europe
8.3. Asia-Pacific
8.3.1. Market by Technology
8.3.2. Market by Diagnostic Method
8.3.3. Market by Product
8.3.4. Market by Pathogen
8.3.5. Market by Testing Type
8.3.6. Country Analysis
8.3.6.1. China
8.3.6.2. Japan
8.3.6.3. India
8.3.6.4. Australia & New Zealand
8.3.6.5. South Korea
8.3.6.6. Asean Countries
8.3.6.7. Rest of Asia-Pacific
8.4. Latin America
8.4.1. Market by Technology
8.4.2. Market by Diagnostic Method
8.4.3. Market by Product
8.4.4. Market by Pathogen
8.4.5. Market by Testing Type
8.4.6. Country Analysis
8.4.6.1. Mexico
8.4.6.2. Brazil
8.4.6.3. Rest of Latin America
8.5. Middle East and Africa
8.5.1. Market by Technology
8.5.2. Market by Diagnostic Method
8.5.3. Market by Product
8.5.4. Market by Pathogen
8.5.5. Market by Testing Type
8.5.6. Country Analysis
8.5.6.1. Saudi Arabia
8.5.6.2. United Arab Emirates
8.5.6.3. Turkey
8.5.6.4. South Africa
8.5.6.5. Rest of Middle East & Africa

9. Competitive Landscape

9.1. Abbott Laboratories
9.2. Becton Dickinson and Company (Cr Bard)
9.3. Biomerieux Sa
9.4. Bruker Corporation
9.5. Cytosorbents
9.6. Danaher Corporation
9.7. EKF Diagnostics
9.8. F Hoffmann-La Roche
9.9. Immunexpress Inc
9.10. Luminex Corporation
9.11. Response Biomedical Corporation
9.12. T2 Biosystems Inc
9.13. Thermo Fisher Scientific Inc

10. Research Methodology & Scope

10.1. Research Scope & Deliverables
10.1.1. Objectives of Study
10.1.2. Scope of Study
10.2. Sources of Data
10.2.1. Primary Data Sources
10.2.2. Secondary Data Sources
10.3. Research Methodology
10.3.1. Evaluation of Proposed Market
10.3.2. Identification of Data Sources
10.3.3. Assessment of Market Determinants
10.3.4. Data Collection
10.3.5. Data Validation & Analysis

List of Tables

Table 1: Global Sepsis Diagnostics Market, Regional Outlook, 2021-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: List of Contracts & Partnerships
Table 5: List of Business Expansions & Divestitures
Table 6: List of Acquisitions & Mergers
Table 7: List of New Product Launches
Table 8: Global Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 9: Global Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 10: Global Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 11: Global Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 12: Gram-Negative Bacteria Causing Sepsis
Table 13: Gram-Positive Bacteria Causing Sepsis
Table 14: Global Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)
Table 15: Global Sepsis Diagnostics Market, by Region, 2021-2028 (In $ Million)
Table 16: North America Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 17: North America Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 18: North America Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 19: North America Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 20: North America Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 21: North America Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)
Table 22: Europe Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 23: Europe Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 24: Europe Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 25: Europe Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 26: Europe Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 27: Europe Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)
Table 28: Asia-Pacific Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 29: Asia-Pacific Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 30: Asia-Pacific Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 31: Asia-Pacific Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 32: Asia-Pacific Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 33: Asia-Pacific Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)
Table 34: Latin America Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 35: Latin America Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 36: Latin America Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 37: Latin America Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 38: Latin America Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 39: Latin America Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)
Table 40: Middle East and Africa Sepsis Diagnostics Market, Country Outlook, 2021-2028 (In $ Million)
Table 41: Middle East and Africa Sepsis Diagnostics Market, by Technology, 2021-2028 (In $ Million)
Table 42: Middle East and Africa Sepsis Diagnostics Market, by Diagnostic Method, 2021-2028 (In $ Million)
Table 43: Middle East and Africa Sepsis Diagnostics Market, by Product, 2021-2028 (In $ Million)
Table 44: Middle East and Africa Sepsis Diagnostics Market, by Pathogen, 2021-2028 (In $ Million)
Table 45: Middle East and Africa Sepsis Diagnostics Market, by Testing Type, 2021-2028 (In $ Million)

List of Figures

Figure 1: Global Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 2: Global Sepsis Diagnostics Market, by Technology, 2020 & 2028 (In %)
Figure 3: Global Sepsis Diagnostics Market, by Microbiology, 2021-2028 (In $ Million)
Figure 4: Global Sepsis Diagnostics Market, by Immunoassay, 2021-2028 (In $ Million)
Figure 5: Global Sepsis Diagnostics Market, by Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 6: Global Sepsis Diagnostics Market, by Other Technologies, 2021-2028 (In $ Million)
Figure 7: Global Sepsis Diagnostics Market, by Diagnostic Method, 2020 & 2028 (In %)
Figure 8: Global Sepsis Diagnostics Market, by Conventional Diagnostics, 2021-2028 (In $ Million)
Figure 9: Global Sepsis Diagnostics Market, by Automated Diagnostics, 2021-2028 (In $ Million)
Figure 10: Global Sepsis Diagnostics Market, by Product, 2020 & 2028 (In %)
Figure 11: Global Sepsis Diagnostics Market, by Blood Culture Media, 2021-2028 (In $ Million)
Figure 12: Global Sepsis Diagnostics Market, by Assay Kits & Reagents, 2021-2028 (In $ Million)
Figure 13: Global Sepsis Diagnostics Market, by Instruments, 2021-2028 (In $ Million)
Figure 14: Global Sepsis Diagnostics Market, by Pathogen, 2020 & 2028 (In %)
Figure 15: Global Sepsis Diagnostics Market, by Gram - Positive and Gram - Negative Bacterial Sepsis, 2021-2028 (In $ Million)
Figure 16: Global Sepsis Diagnostics Market, by Fungal Sepsis, 2021-2028 (In $ Million)
Figure 17: Global Sepsis Diagnostics Market, by Other Pathogens, 2021-2028 (In $ Million)
Figure 18: Global Sepsis Diagnostics Market, by Testing Type, 2020 & 2028 (In %)
Figure 19: Global Sepsis Diagnostics Market, by Laboratory Testing, 2021-2028 (In $ Million)
Figure 20: Global Sepsis Diagnostics Market, by Point-Of-Care Testing, 2021-2028 (In $ Million)
Figure 21: Global Sepsis Diagnostics Market, Regional Outlook, 2020 & 2028 (In %)
Figure 22: United States Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 23: Canada Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 24: Germany Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 25: France Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 26: United Kingdom Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 27: Italy Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 28: Russia Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 29: Spain Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 30: Rest of Europe Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 31: China Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 32: Japan Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 33: India Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 34: Australia & New Zealand Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 35: South Korea Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 36: Asean Countries Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 37: Rest of Asia-Pacific Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 38: Mexico Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 39: Brazil Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 40: Rest of Latin America Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 41: Saudi Arabia Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 42: United Arab Emirates Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 43: Turkey Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 44: South Africa Sepsis Diagnostics Market 2021-2028 (In $ Million)
Figure 45: Rest of Middle East & Africa Sepsis Diagnostics Market 2021-2028 (In $ Million)